LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 15 of 15: Calculated dose-response metrics. - Dataset (ID:20252)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | GR_AOC |
|---|---|---|
| SK-BR-3 | AZD8330 | 0.2909 |
| MCF7 | Pelitinib | 0.2927 |
| BT-20 | Momelotinib | 0.2982 |
| BT-20 | JW-7-24-1 | 0.2993 |
| BT-20 | XMD11-50 | 0.2999 |
| Hs 578T | Crizotinib | 0.3021 |
| Hs 578T | Y39983 | 0.3031 |
| SK-BR-3 | Dasatinib | 0.3036 |
| MDA-MB-231 | Pelitinib | 0.3096 |
| MDA-MB-231 | WZ-4-145 | 0.3146 |
| MDA-MB-231 | Pictilisib | 0.3154 |
| MCF7 | PD184352 | 0.3182 |
| Hs 578T | MK2206 | 0.3187 |
| MCF 10A | QL-XII-47 | 0.3191 |
| SK-BR-3 | LDN-193189 | 0.3261 |
| MDA-MB-231 | PD184352 | 0.3263 |
| MCF 10A | XMD11-50 | 0.3270 |
| MCF7 | YM 201636 | 0.3286 |
| MDA-MB-231 | ZSTK474 | 0.3310 |
| BT-20 | Pelitinib | 0.3310 |
| MCF7 | Afatinib | 0.3327 |
| MCF 10A | GSK1904529A | 0.3328 |
| SK-BR-3 | Momelotinib | 0.3411 |
| BT-20 | Crizotinib | 0.3437 |
| MCF7 | CHIR-99021 | 0.3458 |